Should you buy stock in Eli Lilly right now? Before you buy stock in Eli Lilly, consider this: As you might know, Lilly is a leader in the burgeoning weight-loss drug realm, with approved drugs on sale, and more in development in its pipeline. Speaking of its pipeline, it appears fairly strong -- and getting stronger. One way that's happening is via acquisition; the company recently announced it's spending some $7 billion to buy the privately held company Kelonia Therapeutics -- and its KLN-1010 CAR-T gene ...